These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14982211)

  • 41. Switching methadone: a 10-year experience of 345 patients in an acute palliative care unit.
    Mercadante S
    Pain Med; 2012 Mar; 13(3):399-404. PubMed ID: 22360828
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
    Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
    Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Methadone: a double edged sword.
    Lipman AG
    J Pain Palliat Care Pharmacother; 2005; 19(4):3-4. PubMed ID: 16431826
    [No Abstract]   [Full Text] [Related]  

  • 44. Opioid conversion guidelines for managing adult cancer pain.
    Derby SA
    Am J Nurs; 1999 Oct; 99(10):62-5. PubMed ID: 10542852
    [No Abstract]   [Full Text] [Related]  

  • 45. Divided doses for methadone maintenance.
    Adinoff B
    Am J Psychiatry; 2008 Mar; 165(3):303-5. PubMed ID: 18316426
    [No Abstract]   [Full Text] [Related]  

  • 46. Use of Very-Low-Dose Methadone and Haloperidol for Pain Control in Palliative Care Patients: Are the Sigma-1 Receptors Involved?
    Cobos EJ; Baeyens JM
    J Palliat Med; 2015 Aug; 18(8):660. PubMed ID: 26087240
    [No Abstract]   [Full Text] [Related]  

  • 47. Profound morphine tolerance following high-dose methadone therapy.
    Eugenio KR
    J Pain Palliat Care Pharmacother; 2004; 18(4):47-54. PubMed ID: 15760807
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stereoselective pharmacokinetics of methadone in chronic pain patients.
    Kristensen K; Blemmer T; Angelo HR; Christrup LL; Drenck NE; Rasmussen SN; Sjøgren P
    Ther Drug Monit; 1996 Jun; 18(3):221-7. PubMed ID: 8738759
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Morphine and alternative opioids in cancer pain: the EAPC recommendations.
    Hanks GW; Conno F; Cherny N; Hanna M; Kalso E; McQuay HJ; Mercadante S; Meynadier J; Poulain P; Ripamonti C; Radbruch L; Casas JR; Sawe J; Twycross RG; Ventafridda V;
    Br J Cancer; 2001 Mar; 84(5):587-93. PubMed ID: 11237376
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is it time to replace morphine with methadone for the treatment of pain in the neonatal intensive care unit?
    van den Anker J
    Pediatr Res; 2021 May; 89(7):1608-1609. PubMed ID: 33790411
    [No Abstract]   [Full Text] [Related]  

  • 51. [Methadone in the treatment of chronic non-malignant pain].
    Bendiksen A; McGehee E; Handberg G
    Ugeskr Laeger; 2007 Apr; 169(17):1568-72. PubMed ID: 17484827
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Switching from methadone to tapentadol for cancer pain.
    Mercadante S; Ferrera P; Adile C
    J Pain Symptom Manage; 2012 Sep; 44(3):e3-5. PubMed ID: 22819437
    [No Abstract]   [Full Text] [Related]  

  • 53. Characterization of the early pharmacodynamic profile of oral methadone for cancer-related breakthrough pain: a pilot study.
    Fisher K; Stiles C; Hagen NA
    J Pain Symptom Manage; 2004 Dec; 28(6):619-25. PubMed ID: 15589088
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Morphine and methadone in severe cancer pain--new pharmacokinetic bases for optimal therapy].
    Lööf G; Paalzow L; Jaspersen HP
    Pharm Acta Helv; 1983; 58(7):189-95. PubMed ID: 6889408
    [No Abstract]   [Full Text] [Related]  

  • 55. Opioid switching from morphine to methadone causes a minor but not clinically significant increase in QTc time: A prospective 9-month follow-up study.
    Fredheim OM; Borchgrevink PC; Hegrenaes L; Kaasa S; Dale O; Klepstad P
    J Pain Symptom Manage; 2006 Aug; 32(2):180-5. PubMed ID: 16877186
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High dose levo-methadone treatment for cancer pain in a patient with a history of drug addiction.
    Ostgathe C; Gaertner J; Nauck F; Voltz R
    J Pain Symptom Manage; 2008 Mar; 35(3):229-31. PubMed ID: 18215496
    [No Abstract]   [Full Text] [Related]  

  • 57. Simplified methadone conversion.
    Plonk WM
    J Palliat Med; 2005 Jun; 8(3):478-9. PubMed ID: 16021683
    [No Abstract]   [Full Text] [Related]  

  • 58. Methadone analgesia for persistent pain: safety and toxicity considerations.
    Burgess FW; Pawasauskas J
    Med Health R I; 2008 Sep; 91(9):273-5. PubMed ID: 18834044
    [No Abstract]   [Full Text] [Related]  

  • 59. Pharmacokinetics and pharmacodynamics of methadone enantiomers in hospice patients with cancer pain.
    Auret K; Roger Goucke C; Ilett KF; Page-Sharp M; Boyd F; Oh TE
    Ther Drug Monit; 2006 Jun; 28(3):359-66. PubMed ID: 16778720
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methadone Switching for Cancer Pain: A New Classification of Initiation Protocols, Based on a Critical Literature Review.
    Treillet E; Giet O; Picard S; Laurent S; Seresse L
    J Palliat Med; 2021 Dec; 24(12):1884-1894. PubMed ID: 34851186
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.